Last reviewed · How we verify
TMC125 twice daily — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
TMC125 twice daily (TMC125 twice daily) — St Stephens Aids Trust.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| TMC125 twice daily TARGET | TMC125 twice daily | St Stephens Aids Trust | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- TMC125 twice daily CI watch — RSS
- TMC125 twice daily CI watch — Atom
- TMC125 twice daily CI watch — JSON
- TMC125 twice daily alone — RSS
Cite this brief
Drug Landscape (2026). TMC125 twice daily — Competitive Intelligence Brief. https://druglandscape.com/ci/tmc125-twice-daily. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab